A 60-year-old with chronic coronary disease and diabetes asks about glucose-lowering therapy with cardiovascular benefit beyond metformin. Which is re...

Question

A 60-year-old with chronic coronary disease and diabetes asks about glucose-lowering therapy with cardiovascular benefit beyond metformin. Which is recommended?

Accepted Answer

SGLT2 inhibitor and/or GLP-1 RA with proven CV benefit

Answer

DPP-4 inhibitor (any)

Answer

Basal insulin for all with ASCVD

Answer

Sulfonylurea first

Answer

Thiazolidinedione for HF prevention

us-usmle-step-2 MCQ (SBA): Type 2 Diabetes-CV Risk

A 60-year-old with chronic coronary disease and diabetes asks about glucose-lowering therapy with cardiovascular benefit beyond metformin. Which is recommended?